Carlos Martínez-Pérez

1.0k total citations
28 papers, 665 citations indexed

About

Carlos Martínez-Pérez is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Carlos Martínez-Pérez has authored 28 papers receiving a total of 665 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cancer Research, 17 papers in Oncology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Carlos Martínez-Pérez's work include Breast Cancer Treatment Studies (12 papers), HER2/EGFR in Cancer Research (8 papers) and Cancer Genomics and Diagnostics (6 papers). Carlos Martínez-Pérez is often cited by papers focused on Breast Cancer Treatment Studies (12 papers), HER2/EGFR in Cancer Research (8 papers) and Cancer Genomics and Diagnostics (6 papers). Carlos Martínez-Pérez collaborates with scholars based in United Kingdom, United States and Malaysia. Carlos Martínez-Pérez's co-authors include Arran Turnbull, James Meehan, Mark Gray, Simon P. Langdon, Charlene Kay, Carol Ward, Lisa Y. Pang, David J. Argyle, Andrew H. Sims and Peter Mullen and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Carlos Martínez-Pérez

28 papers receiving 658 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carlos Martínez-Pérez United Kingdom 13 281 245 231 142 62 28 665
Bozhi Shi China 4 443 1.6× 277 1.1× 267 1.2× 98 0.7× 47 0.8× 7 764
Ellen Tully United States 11 472 1.7× 270 1.1× 288 1.2× 136 1.0× 74 1.2× 16 796
Khadijeh Barzaman Iran 7 384 1.4× 236 1.0× 256 1.1× 134 0.9× 57 0.9× 8 769
Linghuan Zhang China 4 469 1.7× 256 1.0× 334 1.4× 140 1.0× 53 0.9× 8 996
Sunali Mehta New Zealand 17 431 1.5× 188 0.8× 224 1.0× 91 0.6× 26 0.4× 39 772
Haijun Yu China 17 335 1.2× 126 0.5× 272 1.2× 109 0.8× 37 0.6× 54 777
Peng Ji China 11 391 1.4× 349 1.4× 375 1.6× 215 1.5× 52 0.8× 32 870
Guangchun He China 15 478 1.7× 297 1.2× 323 1.4× 176 1.2× 38 0.6× 25 952
Elahe Safari Iran 10 419 1.5× 233 1.0× 284 1.2× 139 1.0× 53 0.9× 35 887

Countries citing papers authored by Carlos Martínez-Pérez

Since Specialization
Citations

This map shows the geographic impact of Carlos Martínez-Pérez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos Martínez-Pérez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos Martínez-Pérez more than expected).

Fields of papers citing papers by Carlos Martínez-Pérez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlos Martínez-Pérez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos Martínez-Pérez. The network helps show where Carlos Martínez-Pérez may publish in the future.

Co-authorship network of co-authors of Carlos Martínez-Pérez

This figure shows the co-authorship network connecting the top 25 collaborators of Carlos Martínez-Pérez. A scholar is included among the top collaborators of Carlos Martínez-Pérez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlos Martínez-Pérez. Carlos Martínez-Pérez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kay, Charlene, Carlos Martínez-Pérez, J. Michael Dixon, & Arran Turnbull. (2023). The Role of Nodes and Nodal Assessment in Diagnosis, Treatment and Prediction in ER+, Node-Positive Breast Cancer. Journal of Personalized Medicine. 13(10). 1476–1476. 4 indexed citations
2.
Martínez-Pérez, Carlos, Arran Turnbull, Charlene Kay, & J. Michael Dixon. (2023). Neoadjuvant endocrine therapy in postmenopausal women with HR+/HER2- breast cancer. Expert Review of Anticancer Therapy. 23(1). 67–86. 5 indexed citations
3.
He, Xiaping, Lorna Renshaw, Carlos Martínez-Pérez, et al.. (2022). Integrated DNA and RNA Sequencing Reveals Drivers of Endocrine Resistance in Estrogen Receptor–Positive Breast Cancer. Clinical Cancer Research. 28(16). 3618–3629. 11 indexed citations
4.
Meehan, James, Mark Gray, Carlos Martínez-Pérez, et al.. (2021). A Novel Approach for the Discovery of Biomarkers of Radiotherapy Response in Breast Cancer. Journal of Personalized Medicine. 11(8). 796–796. 10 indexed citations
5.
Martínez-Pérez, Carlos, Charlene Kay, James Meehan, et al.. (2021). The IL6-like Cytokine Family: Role and Biomarker Potential in Breast Cancer. Journal of Personalized Medicine. 11(11). 1073–1073. 11 indexed citations
6.
Meehan, James, Mark Gray, Carlos Martínez-Pérez, et al.. (2021). Tissue- and Liquid-Based Biomarkers in Prostate Cancer Precision Medicine. Journal of Personalized Medicine. 11(7). 664–664. 12 indexed citations
7.
Dixon, J. Michael, et al.. (2020). Factors affecting the number of sentinel lymph nodes removed in patients having surgery for breast cancer. Breast Cancer Research and Treatment. 184(2). 335–343. 11 indexed citations
8.
Gray, Mark, James Meehan, Arran Turnbull, et al.. (2020). The Importance of the Tumor Microenvironment and Hypoxia in Delivering a Precision Medicine Approach to Veterinary Oncology. Frontiers in Veterinary Science. 7. 598338–598338. 5 indexed citations
9.
Turnbull, Arran, Samir Patel, Carlos Martínez-Pérez, Anne Rigg, & Olga Oikonomidou. (2020). Risk of chemotherapy-related amenorrhoea (CRA) in premenopausal women undergoing chemotherapy for early stage breast cancer. Breast Cancer Research and Treatment. 186(1). 237–245. 8 indexed citations
10.
Turnbull, Arran, Çiğdem Selli, Carlos Martínez-Pérez, et al.. (2020). Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: comparison of gene expression profiling approaches. BMC Bioinformatics. 21(1). 30–30. 36 indexed citations
11.
Gray, Mark, James Meehan, Carlos Martínez-Pérez, et al.. (2020). Naturally-Occurring Canine Mammary Tumors as a Translational Model for Human Breast Cancer. Frontiers in Oncology. 10. 617–617. 78 indexed citations
12.
Meehan, James, Mark Gray, Carlos Martínez-Pérez, et al.. (2020). Precision Medicine and the Role of Biomarkers of Radiotherapy Response in Breast Cancer. Frontiers in Oncology. 10. 628–628. 42 indexed citations
13.
Turnbull, Arran, et al.. (2019). On-treatment biomarkers can improve prediction of response to neoadjuvant chemotherapy in breast cancer. Breast Cancer Research. 21(1). 73–73. 38 indexed citations
14.
Gray, Mark, Arran Turnbull, Carol Ward, et al.. (2019). Development and characterisation of acquired radioresistant breast cancer cell lines. Radiation Oncology. 14(1). 64–64. 74 indexed citations
15.
Arthur, Laura, Carlos Martínez-Pérez, Lorna Renshaw, et al.. (2019). Abstract P3-10-26: Predicting benefit from HER2-targeted therapies in patients with ER+/HER2+ breast cancer. Cancer Research. 79(4_Supplement). P3–10. 1 indexed citations
16.
Jarman, Edward J., Carol Ward, Arran Turnbull, et al.. (2019). HER2 regulates HIF-2α and drives an increased hypoxic response in breast cancer. Breast Cancer Research. 21(1). 10–10. 52 indexed citations
17.
Martínez-Pérez, Carlos, Arran Turnbull, & J. Michael Dixon. (2018). The evolving role of receptors as predictive biomarkers for metastatic breast cancer. Expert Review of Anticancer Therapy. 19(2). 121–138. 11 indexed citations
18.
Martínez-Pérez, Carlos, et al.. (2018). Abstract P5-11-02: Predicting local recurrence in patients treated for ductal carcinoma in situ of the breast (DCIS). Cancer Research. 78(4_Supplement). P5–11. 1 indexed citations
19.
Martínez-Pérez, Carlos, Arran Turnbull, Laura Arthur, et al.. (2017). Current treatment trends and the need for better predictive tools in the management of ductal carcinoma in situ of the breast. Cancer Treatment Reviews. 55. 163–172. 29 indexed citations
20.
Martínez-Pérez, Carlos, Carol Ward, Arran Turnbull, et al.. (2016). Antitumour activity of the novel flavonoid Oncamex in preclinical breast cancer models. British Journal of Cancer. 114(8). 905–916. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bozhi Shi Breakdown of academic impact, for papers by Ellen Tully Breakdown of academic impact, for papers by Khadijeh Barzaman Breakdown of academic impact, for papers by Linghuan Zhang Breakdown of academic impact, for papers by Sunali Mehta Breakdown of academic impact, for papers by Haijun Yu Breakdown of academic impact, for papers by Peng Ji Breakdown of academic impact, for papers by Guangchun He Breakdown of academic impact, for papers by Elahe Safari
Rankless by CCL
2026